A Blood Sugar of 6: What It Means and How to Measure It Properly

“6” is two different measurements depending on where you live and what was tested. A blood glucose of 6 mmol/L is 108 mg/dL. If that was a fasting venous draw, it sits in the impaired fasting glucose band (100–125 mg/dL, 5.6–6.9 mmol/L). If it was two hours after a meal, or random, 108 mg/dL is unremarkable. An A1C of 6.0% is the estimated glycation of hemoglobin over the previous ~8–12 weeks and falls in the 5.7–6.4% band. A glucose of 8 mmol/L is 144 mg/dL, which is high for fasting and normal at 45 minutes after eating. Conversion is mg/dL = mmol/L × 18.0182. None of these single numbers is a diagnosis, and the thresholds themselves are population cutoffs that a clinician applies with repeat testing.

The more useful question for someone with data access: what would you have to measure to know whether a 6 means anything about you?

A single fasting glucose is a noisy measurement

Within-person biological variation in fasting plasma glucose is roughly 5% CV. On top of that, preanalytical handling matters more than most people expect. Whole blood left in a plain tube keeps glycolyzing, and glucose falls by several percent per hour at room temperature. If your draw sat before centrifugation, your 108 might have been 115. If the lab used sodium fluoride/potassium oxalate, inhibition is incomplete for the first hour or two. Citrate-buffered tubes stop glycolysis faster and read a few mg/dL higher than fluoride tubes on the same blood.

Practically: take a fasting glucose of 108 mg/dL, measured once on an unknown tube type after a night of poor sleep. It is one sample from a distribution whose width you have not estimated. Two or three fasting draws on separate mornings, with the same lab and the same tube type, tell you where your distribution center sits.

A1C measures hemoglobin as much as it measures glucose

A1C is glucose exposure integrated over the lifespan of circulating red cells, weighted toward the last 30 days. Anything that changes red cell turnover shifts the number without changing your glucose. Iron deficiency raises A1C. Hemolysis, recent blood loss, erythropoietin therapy, pregnancy, and splenomegaly lower it by shortening mean red cell age. Chronic kidney disease and liver disease push it in both directions depending on mechanism ¹². Hemoglobin variants (HbS, HbC, HbE trait) interfere with some assay chemistries. The direction of the error depends on whether the lab runs HPLC, immunoassay, or boronate affinity ².

If you have a genome, check it. HBB variants and G6PD deficiency alleles are common enough to matter and are reported by most sequencing pipelines. If you carry one, ask which A1C method your lab uses and whether that method is known to be affected. Fructosamine and glycated albumin reflect ~2–3 weeks of exposure and do not depend on red cell lifespan, which makes them the right substitutes when A1C is untrustworthy ¹. 1,5-anhydroglucitol falls specifically in response to glucose spilling into urine, so it tracks postprandial excursions rather than mean glucose ³.

The practical consequence: a 6.1% A1C with a mean CGM glucose of 95 mg/dL is telling you something about your red cells. A 6.1% with a mean CGM glucose of 135 mg/dL is telling you something about your glucose.

CGM is the measurement that resolves the ambiguity

Two weeks of continuous glucose gives you roughly 4,000 readings at 5-minute resolution instead of one. That is enough to estimate mean, variability, and the shape of your postprandial curves ⁴⁵.

Know the instrument’s limits. Modern sensors run around 9–10% MARD against reference, with worse accuracy in the first 12–24 hours after insertion and at low glucose ⁴⁶. Sensors measure interstitial fluid, which lags plasma by roughly 5–10 minutes, so a rapidly rising post-meal curve reads low and the peak reads late ⁵. Overnight “compression lows” from sleeping on the sensor are an artifact, not hypoglycemia: look for a sharp drop with an equally sharp recovery and no symptoms. Older Dexcom generations were sensitive to acetaminophen. Abbott Libre sensors are sensitive to high-dose ascorbic acid.

Export the raw data rather than reading the app summary:

• Dexcom Clarity: CSV with Timestamp (YYYY-MM-DDThh:mm:ss), Event Type, Glucose Value (mg/dL). Values clamp at Low and High strings outside 40–400.
• FreeStyle Libre (LibreView): CSV with Device Timestamp, Record Type and Historic Glucose mg/dL. Record types are 0 = historic 15-min, 1 = scan and 5 = notes.
• Nightscout: entries collection, sgv field, date in epoch ms. Pull with curl "$NS_URL/api/v1/entries.json?count=100000&find[dateString][\$gte]=2026-01-01".

Then compute, in pandas:

df = df.dropna(subset=["glucose"]).set_index("ts").sort_index()
mean = df.glucose.mean()
gmi  = 3.31 + 0.02392 * mean          # GMI %, mg/dL input
cv   = df.glucose.std() / mean * 100
tir  = ((df.glucose >= 70) & (df.glucose <= 180)).mean() * 100
titr = ((df.glucose >= 70) & (df.glucose <= 140)).mean() * 100

Three numbers to look at. GMI is what your A1C “should” be given your measured mean glucose. A gap of more than ~0.3–0.5 points between GMI and lab A1C points at the hemoglobin issues above ¹. CV below 36% is the usual dividing line between stable and variable glucose, and variability is partly independent of the mean ⁵⁷. Time in tight range (70–140 mg/dL) discriminates far better than 70–180 in people whose glucose is mostly normal, because TIR saturates near 100% and stops carrying information ⁸.

For anyone whose readings hover around 6 mmol/L, TITR and CV are the metrics that move. TIR will read 98–100% and tell you nothing.

Designing an n-of-1 meal test

Standardize the challenge or the data is uninterpretable. Pick a fixed carbohydrate load. A 75 g glucose drink is the reference, and a repeatable real meal is more informative about your life. Eat it at the same time of day after an 8-hour fast, and stay sedentary for 2 hours. Repeat it on three non-consecutive days.

Extract per trial:

• Baseline: mean of the 15 minutes before the first bite.
• Peak value and time to peak.
• Value at 60 and 120 minutes.
• Incremental AUC over 2 hours by trapezoid, with area below baseline dropped.

The reason for three replicates: the same meal in the same person varies by a substantial fraction of the response, driven by prior night’s sleep, prior meal, activity, and stress. One trial gives you a point with no error bar. Three gives you a crude standard error, enough to say whether meal A and meal B differ for you.

Compare your curve shape. Do not stop at the 2-hour number. A peak of 165 mg/dL at 40 minutes that is back to baseline at 90 minutes is a different physiology than a peak of 145 mg/dL at 90 minutes still elevated at 150. Both can produce the same A1C.

When to stop analyzing and call a clinician

Fasting glucose repeatedly at or above 126 mg/dL (7.0 mmol/L), A1C at or above 6.5%, a 2-hour OGTT at or above 200 mg/dL (11.1 mmol/L), or any random glucose above 200 with thirst, frequent urination, or unexplained weight loss: that is a clinical evaluation. It is not a data project. Very high glucose with nausea, vomiting, abdominal pain, or fast deep breathing is an emergency and needs urgent care the same day. On the low side, confirmed glucose below 54 mg/dL (3.0 mmol/L) is clinically significant hypoglycemia and needs medical evaluation, especially in someone not taking glucose-lowering medication. CGM is a monitoring instrument, and what to do about any of these numbers is a decision for a physician ⁹¹⁰.

Questions people also ask

Is a blood glucose of 6 bad? 6 mmol/L is 108 mg/dL. Fasting, it falls in the impaired fasting glucose range (100–125 mg/dL). That range is a flag to measure more carefully. It is not a diagnosis. After a meal it is entirely ordinary. The measurement context determines the meaning.

Is 6.0 borderline diabetic? An A1C of 6.0% is in the 5.7–6.4% band that the ADA labels prediabetes. It is a statistical risk category based on population data, and it can be distorted by red cell turnover and hemoglobin variants ¹². Confirm it with a second test and, ideally, with a CGM-derived mean glucose before treating the number as real.

Should I be worried about a 6.1 A1C? Worry is the wrong frame for a single measurement with known assay interference. Repeat it, get a fasting glucose on the same draw, and wear a CGM for two weeks. If your GMI comes out near 6.1% as well, the two methods agree and you have a real signal. If GMI comes out at 5.5%, investigate the hemoglobin side ¹.

What is the highest you should let your blood sugar go? That is a treatment target question, which belongs to your clinician. As a measurement convention, the standard CGM ranges are 70–180 mg/dL for time in range and 70–140 mg/dL for time in tight range, and the tighter range is the one that distinguishes people whose glucose is already mostly normal ⁸.

Does an A1C of 6.1 require medication? Prescribing decisions are not something we or any analysis pipeline can make. Bring the A1C, the repeat, the fasting glucose, and the CGM export to a physician.

Footnotes

1. Michelle D. Lundholm, Mary Ann Emanuele, Alina Ashraf, et al. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring. Journal of Diabetes and its Complications, 2020. https://doi.org/10.1016/j.jdiacomp.2020.107585 ↩ ↩² ↩³ ↩⁴ ↩⁵

2. Michael S. Radin. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading. Journal of General Internal Medicine, 2013. https://doi.org/10.1007/s11606-013-2595-x ↩ ↩² ↩³

3. Kathleen M. Dungan, John B. Buse, Joseph Largay, et al. 1,5-Anhydroglucitol and Postprandial Hyperglycemia as Measured by Continuous Glucose Monitoring System in Moderately Controlled Patients With Diabetes. Diabetes Care, 2006. https://doi.org/10.2337/dc06-1910 ↩

4. David C. Klonoff, David Ahn, Andjela Drincic. Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Research and Clinical Practice, 2017. https://doi.org/10.1016/j.diabres.2017.08.005 ↩ ↩²

5. David Rodbard. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technology & Therapeutics, 2016. https://doi.org/10.1089/dia.2015.0417 ↩ ↩² ↩³

6. Sandeep Vashist. Continuous Glucose Monitoring Systems: A Review. Diagnostics, 2013. https://doi.org/10.3390/diagnostics3040385 ↩

7. D. Capoccia, F. Coccia, A. Guida, et al. Is Type 2 Diabetes Really Resolved after Laparoscopic Sleeve Gastrectomy? Glucose Variability Studied by Continuous Glucose Monitoring. Journal of Diabetes Research, 2015. https://doi.org/10.1155/2015/674268 ↩

8. Timothy C. Dunn, Ramzi A. Ajjan, Richard M. Bergenstal, et al. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes. Diabetes Technology & Therapeutics, 2024. https://doi.org/10.1089/dia.2023.0565 ↩ ↩²

9. Rajesh Naidu Janapala, Joseph S Jayaraj, Nida Fathima, et al. Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis. Cureus, 2019. https://doi.org/10.7759/cureus.5634 ↩

10. L. B. E. A. Hoeks, W. L. Greven, H. W. de Valk. Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review. Diabetic Medicine, 2011. https://doi.org/10.1111/j.1464-5491.2010.03177.x ↩